177 related articles for article (PubMed ID: 31108234)
1. Longer follow-up continues to reveal no increased risk of cancer with the use of recombinant human bone morphogenetic protein in spine fusion.
Dettori JR; Chapman JR; DeVine JG; McGuire RA; Junge MR; Norvell DC
Spine J; 2019 Oct; 19(10):1640-1647. PubMed ID: 31108234
[TBL] [Abstract][Full Text] [Related]
2. The Risk of Cancer With the Use of Recombinant Human Bone Morphogenetic Protein in Spine Fusion.
Dettori JR; Chapman JR; DeVine JG; McGuire RA; Norvell DC; Weiss NS
Spine (Phila Pa 1976); 2016 Aug; 41(16):1317-1324. PubMed ID: 27261568
[TBL] [Abstract][Full Text] [Related]
3. Comparison of transforaminal lumbar interbody fusion outcomes in patients receiving rhBMP-2 versus autograft.
Khan TR; Pearce KR; McAnany SJ; Peters CM; Gupta MC; Zebala LP
Spine J; 2018 Mar; 18(3):439-446. PubMed ID: 28822825
[TBL] [Abstract][Full Text] [Related]
4. Nerve injury and recovery after lateral lumbar interbody fusion with and without bone morphogenetic protein-2 augmentation: a cohort-controlled study.
Lykissas MG; Aichmair A; Sama AA; Hughes AP; Lebl DR; Cammisa FP; Girardi FP
Spine J; 2014 Feb; 14(2):217-24. PubMed ID: 24269858
[TBL] [Abstract][Full Text] [Related]
5. Perioperative complications of recombinant human bone morphogenetic protein-2 on an absorbable collagen sponge versus iliac crest bone graft for posterior cervical arthrodesis.
Crawford CH; Carreon LY; McGinnis MD; Campbell MJ; Glassman SD
Spine (Phila Pa 1976); 2009 Jun; 34(13):1390-4. PubMed ID: 19440166
[TBL] [Abstract][Full Text] [Related]
6. Bone morphogenetic protein use in spine surgery in the United States: how have we responded to the warnings?
Guzman JZ; Merrill RK; Kim JS; Overley SC; Dowdell JE; Somani S; Hecht AC; Cho SK; Qureshi SA
Spine J; 2017 Sep; 17(9):1247-1254. PubMed ID: 28456674
[TBL] [Abstract][Full Text] [Related]
7. Usage of recombinant human bone morphogenetic protein in cervical spine procedures: analysis of the MarketScan longitudinal database.
Cole T; Veeravagu A; Jiang B; Ratliff JK
J Bone Joint Surg Am; 2014 Sep; 96(17):1409-16. PubMed ID: 25187578
[TBL] [Abstract][Full Text] [Related]
8. Routine use of recombinant human bone morphogenetic protein-2 in posterior fusions of the pediatric spine and incidence of cancer.
Sayama C; Willsey M; Chintagumpala M; Brayton A; Briceño V; Ryan SL; Luerssen TG; Hwang SW; Jea A
J Neurosurg Pediatr; 2015 Jul; 16(1):4-13. PubMed ID: 25860984
[TBL] [Abstract][Full Text] [Related]
9. Bone Morphogenetic Proteins in Spinal Surgery: What Is the Fusion Rate and Do They Cause Cancer?
Malham GM; Giles GG; Milne RL; Blecher CM; Brazenor GA
Spine (Phila Pa 1976); 2015 Nov; 40(22):1737-42. PubMed ID: 26730525
[TBL] [Abstract][Full Text] [Related]
10. Cancer risk after use of recombinant bone morphogenetic protein-2 for spinal arthrodesis.
Carragee EJ; Chu G; Rohatgi R; Hurwitz EL; Weiner BK; Yoon ST; Comer G; Kopjar B
J Bone Joint Surg Am; 2013 Sep; 95(17):1537-45. PubMed ID: 24005193
[TBL] [Abstract][Full Text] [Related]
11. Adverse effects associated with high-dose recombinant human bone morphogenetic protein-2 use in anterior cervical spine fusion.
Shields LB; Raque GH; Glassman SD; Campbell M; Vitaz T; Harpring J; Shields CB
Spine (Phila Pa 1976); 2006 Mar; 31(5):542-7. PubMed ID: 16508549
[TBL] [Abstract][Full Text] [Related]
12. The perioperative cost of Infuse bone graft in posterolateral lumbar spine fusion.
Glassman SD; Carreon LY; Campbell MJ; Johnson JR; Puno RM; Djurasovic M; Dimar JR
Spine J; 2008; 8(3):443-8. PubMed ID: 17526436
[TBL] [Abstract][Full Text] [Related]
13. Use of polyetheretherketone spacer and recombinant human bone morphogenetic protein-2 in the cervical spine: a radiographic analysis.
Klimo P; Peelle MW
Spine J; 2009 Dec; 9(12):959-66. PubMed ID: 19574105
[TBL] [Abstract][Full Text] [Related]
14. Use of recombinant human bone morphogenetic protein-2 to achieve posterolateral lumbar spine fusion in humans: a prospective, randomized clinical pilot trial: 2002 Volvo Award in clinical studies.
Boden SD; Kang J; Sandhu H; Heller JG
Spine (Phila Pa 1976); 2002 Dec; 27(23):2662-73. PubMed ID: 12461392
[TBL] [Abstract][Full Text] [Related]
15. Complications of anterior cervical discectomy and fusion using recombinant human bone morphogenetic protein-2.
Vaidya R; Carp J; Sethi A; Bartol S; Craig J; Les CM
Eur Spine J; 2007 Aug; 16(8):1257-65. PubMed ID: 17387522
[TBL] [Abstract][Full Text] [Related]
16. Nationwide practice patterns in the use of recombinant human bone morphogenetic protein-2 in pediatric spine surgery as a function of patient-, hospital-, and procedure-related factors.
Lam SK; Sayama C; Harris DA; Briceño V; Luerssen TG; Jea A
J Neurosurg Pediatr; 2014 Nov; 14(5):476-85. PubMed ID: 25171721
[TBL] [Abstract][Full Text] [Related]
17. Is it safe to use recombinant human bone morphogenetic protein in posterior cervical fusion?
Hiremath GK; Steinmetz MP; Krishnaney AA
Spine (Phila Pa 1976); 2009 Apr; 34(9):885-9. PubMed ID: 19531997
[TBL] [Abstract][Full Text] [Related]
18. rhBMP use in cervical spine surgery: associated factors and in-hospital complications.
Jain A; Hassanzadeh H; Strike SA; Skolasky RL; Riley LH
J Bone Joint Surg Am; 2014 Apr; 96(8):617-23. PubMed ID: 24740657
[TBL] [Abstract][Full Text] [Related]
19. Effectiveness and harms of recombinant human bone morphogenetic protein-2 in spine fusion: a systematic review and meta-analysis.
Fu R; Selph S; McDonagh M; Peterson K; Tiwari A; Chou R; Helfand M
Ann Intern Med; 2013 Jun; 158(12):890-902. PubMed ID: 23778906
[TBL] [Abstract][Full Text] [Related]
20. Complications of rhBMP-2 utilization for posterolateral lumbar fusions requiring reoperation: a single practice, retrospective case series report.
Hoffmann MF; Jones CB; Sietsema DL
Spine J; 2013 Oct; 13(10):1244-52. PubMed ID: 23973099
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
